Navigation Links
Nektar Therapeutics Reports First Quarter 2009 Financial Results
Date:5/6/2009

Property and equipment, net 75,020 73,578 Goodwill 76,501 76,501 Other assets 3,823 4,237 ----- ----- Total assets $505,939 $560,536 ======== ======== LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $2,675 $13,832 Accrued compensation 5,437 11,570 Accrued clinical trial expenses 14,982 17,622 Accrued expenses 11,583 9,923 Deferred revenue, current portion 8,416 10,010 Interest payable 58 1,805 Other current liabilities 3,486 3,612 ----- ----- Total current liabilities 46,637 68,374 Convertible subordinated notes 214,955 214,955 Capital lease obligations 19,989 20,347 Deferred revenue 54,132 55,567 Deferred gain 5,682 5,901 Other long-term liabilities 5,270 5,238 ----- ----- Total liabilities 346,665 370,382 Commitments and contingencies Stockholders' equity: Preferred stock - - Common stock 9 9 Capital in excess of par value 1,315,182 1,312,796 Accumulated other comprehensive income (loss) (20) 1,439
'/>"/>
SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
2. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
3. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
4. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
5. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
6. Nektar Therapeutics to Present at 2007 BMO Capital Markets Focus on Healthcare Conference
7. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
8. Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors
9. Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
10. West Concludes Agreement with Nektar
11. Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Corporation (Nasdaq: MATK ) today announced its financial ... October 31, 2009. Revenues for the fourth quarter were ... fourth quarter of fiscal 2008. Net income was $11.0 ... quarter of fiscal 2009, a 5% increase compared with ... year,s fourth quarter. The fourth quarter of fiscal ...
(Date:12/16/2009)... in suspended solution by swimming , ... ... at the U.S. Department of Energy’s (DOE) Argonne National Laboratory ... can turn microgears when suspended in a solution, providing insights ... , ,“The gears are a million times more massive than ...
(Date:12/16/2009)... Decision Resources, one of the world,s ... healthcare issues, finds that, according to responses from ... briakinumab (both interleukin inhibitors) will capture 22 percent ... drug market for moderate to severe psoriasis. Among ... capturing nearly three times as much patient share ...
(Date:12/16/2009)... conducted pursuant to Special Protocol Assessment with ... CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna Zentaris ... (the "Company"), a global biopharmaceutical company focused ... the initiation, by its partner Keryx Biopharmaceuticals ... 3 registration clinical trial for perifosine (KRX-0401), ...
Breaking Biology Technology:Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Argonne Scientists Use Bacteria to Power Simple Machines 2Argonne Scientists Use Bacteria to Power Simple Machines 3In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5
... policy areas that the new administration must address will ... technology that has been compared with the industrial revolution ... right decisions are made, nanotechnology will bring vast improvements ... wrong decisions are made, the American economy, human health ...
... MADISON, N.J., July 9 Wyeth (NYSE: WYE ... of law on the,punitive damages award in the hormone therapy ... Eastern District of Arkansas, has been,granted by the court. This ... Little Rock jury last year. The decision also,clears the way ...
... First sales for revolutionary CTO Crossing System after ... Israeli medical device company, has announced today the ... product-line for angiographic procedures in the peripheral vasculature. ... the treatment of chronic complete arterial blockage (CTO). ...
Other Biology Technology:Wyeth's Motion to Overturn Punitive Damages Award Granted by Arkansas Court 2Wyeth's Motion to Overturn Punitive Damages Award Granted by Arkansas Court 3Ovalum Ltd. Announces Sales Launch of CiTop™ Product-Line in Europe 2
(Date:12/16/2009)... Medicine researcher will lead the coordinating center for a ... field of stem cell research. Michael L. Terrin, M.D.,C.M.,M.P.H., ... the National Heart, Lung and Blood Institute (NHLBI) to ... which will be called the NHLBI Progenitor Cell Biology ... $30 million grant over seven years. , ...
(Date:12/16/2009)... 1 GestureTek Inc. today announced ... - a turnkey, portable, plug and play ... entertainment and touring promotions. GestureTek is the ... in camera-enabled gesture recognition technology for interactive ... for quality, the CUBE has TUV, CE, ...
(Date:12/16/2009)... REDWOOD SHORES, Calif. and PALM HARBOR, Fla., ... ("CIC") (OTC Bulletin Board: CICI), a leading ... process automation in the financial industry* and ... and Docubase Systems Inc. ("Docubase"), a leading ... announced today that they have entered an ...
Breaking Biology News(10 mins):University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Jewish Stem Cell Donor Urgently Sought for Young NJ Man Battling Aggressive Non Hodgkin Lymphoma 56213 1Jewish Stem Cell Donor Urgently Sought for Young NJ Man Battling Aggressive Non Hodgkin Lymphoma 56213 2Jewish Stem Cell Donor Urgently Sought for Young NJ Man Battling Aggressive Non Hodgkin Lymphoma 56213 3Discoveries Brighten Search for AIDS Vaccine 56210 1Discoveries Brighten Search for AIDS Vaccine 56210 2Discoveries Brighten Search for AIDS Vaccine 56210 3Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 1Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 2Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 3Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 4Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 5Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 6Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 7Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 8Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 9Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 10Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 11Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 12Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 13Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 14Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 15Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 16Reportlinker Adds Cosmetic Surgery Markets 3A Products and Services Report 56206 17
... scientists are joining forces to conceptualize, develop and bring ... century health care through UC San Diego,s new Institute ... molecular-sized bridges to repair damaged hearts, and scarless surgery ... in California with the new Institute leading the way. ...
... an instrument designed to help determine the shapes and ... in high-altitude clouds, down to the micron level (comparable ... to a new study in Optics Letters, ... produced using this instrument likely will help improve computer ...
... children with autism evaluate facial expressions differently than the ... is strikingly similar to autistic patients themselves, according to ... University of North Carolina at Chapel Hill and neuroscientist ... , Piven, Adolphs and colleague Michael Spezio, Ph.D., ...
Other Biology News:UC San Diego launches Institute of Engineering in Medicine to accelerate health care tech 2UC San Diego launches Institute of Engineering in Medicine to accelerate health care tech 3Scientists demonstrate the sharpest measurement of ice crystals in clouds 2UNC, Caltech research finds further evidence for genetic contribution to autism 2UNC, Caltech research finds further evidence for genetic contribution to autism 3
GOAT ANTI HUMAN PARAINFLUENZA VIRUS 2+3...
... The Varian Cary 50 Microplate ... your cost per analysis by ... of the award-winning Cary 50 ... up to 384 samples in ...
IMAGEQUANT 300 WKSTN, 1 EA. Category: ImageQuant CCD Imagers....
PAb to Hu-IFN-Alpha/Beta R2 [(IFNAR2) CD118], Rabbit Serum, neutralizing Binds to but does not neutralize human interferon alpha/beta receptor...
Biology Products: